Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Hypoprothrombinemias

ClinicalTrials.gov lists 1 trial for Hypoprothrombinemias or a narrower condition beneath it.

MeSH D007020 Hemic and Lymphatic Diseases C15 C16 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 4 Prevalence Prevalence 1 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 4 Prevalence Prevalence 1

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Hypoprothrombinemias itself; the rest are tagged with a narrower condition beneath it.

Get the Hypoprothrombinemias report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Hypoprothrombinemias trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2014 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Hypoprothrombinemias trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 1/2 1

How many Hypoprothrombinemias trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Hypoprothrombinemias? (4)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 2019 Yes
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety. American journal of surgery 1988 Yes
Determinants of antibiotic-associated hypoprothrombinemia. Pharmacotherapy 1987 Yes
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of thrombosis and haemostasis : JTH 2004 No

Prevalence (1)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Congenital factor II deficiency Point prevalence <1 / 1 000 000 Europe Not stated Unspecified

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages